Zhisong He

People's Bank of China — China

Medicine · Health Sciences

36h-index4.4kcitations267works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(67), Esophageal Cancer Research and Treatment(65), Renal cell carcinoma treatment(57), Renal and related cancers(31), Urinary and Genital Oncology Studies(30)

Publications267 total

Correction: Opening the black box: defining true-negative outcomes in esophageal cancer screening — a population-based study
BMC Medicine·2025Open Access
Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study
npj Precision Oncology·2025Open Access
Opening the black box: defining true-negative outcomes in esophageal cancer screening — a population-based study
BMC Medicine·2025· 1 citedOpen Access
Safety and Efficacy of Aprotinin in Coronary Artery Bypass Surgery: Insights from a Multi-Center Retrospective Study
2025Open Access
T10SLRE: A novel ensemble learning approach for rapid and non-destructive prediction of bread loaf volume in wheat using NIR spectroscopy
Food Chemistry·2025
SMARCB1 (INI-1)-Deficient Myoepithelioma-Like Tumor in the Perineal Region of a Male Patient: A Case Report
International Journal of Surgical Pathology·2025· 1 cited
Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers
BMC Cancer·2025Open Access
Mechanisms, Clinical Trials, and New Treatments for <scp>BCG</scp> ‐Unresponsive in Nonmuscle Invasive Bladder Cancer
Cancer Medicine·2025· 1 citedOpen Access
Effect of risk-based screening for upper gastrointestinal cancers: a multi-center real-world study
British Journal of Cancer·2025Open Access
Efficacy and safety of first-line treatments for metastatic castration-resistant prostate cancer based on phase II and III randomized controlled trials: A PROSTA-MAP systematic review and network meta-analysis
Chinese Medical Journal·2025Open Access
Robotic versus open level III-IV inferior vena cava thrombectomy: A multicenter, retrospective, propensity-matched analysis
European Journal of Surgical Oncology·2025
Early-life undernutrition increases the risk of death from chronic diseases in adulthood: a population-based cohort study
Global Health Research and Policy·2025· 3 citedOpen Access
Extremely early genomic events and temporal order of esophageal squamous cell carcinogenesis: Longitudinal self-comparison of progressors and non-progressors
The American Journal of Human Genetics·2025Open Access
514 | CAN BASELINE 18F‐FDG PET/CT PREDICT THE PROGNOSIS OF PRIMARY CNS LYMPHOMA?
Hematological Oncology·2025Open Access
688 | INTRAVENOUS MIDDLE‐DOSE METHOTREXATE INCORPORATED INTO R‐CHOP PREVENTED CENTRAL NERVOUS SYSTEM RELAPSE IN HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS
Hematological Oncology·2025Open Access
697 | NOVEL SMALL MOLECULAR TARGET AGENTS WITH HD‐MTX‐BASED REGIMENS IMPROVED REMISSION RATES WITHOUT PROLONGING PFS IN NEWLY DIAGNOSED PCNSL
Hematological Oncology·2025Open Access
702 | ORAL LENALIDOMIDE OR BTK INHIBITORS AS MAINTENANCE THERAPY SHOWED DURABLE EFFICACY AFTER THE FIRST REMISSION IN PCNSL PATIENTS
Hematological Oncology·2025Open Access
720 | THE TREATMENT EVOLUTION OF CLASSIC HODGKIN LYMPHOMA OVER TWO DECADES IN CHINA: REAL‐WORLD EXPERIENCES OF AN ACADEMIC CENTER
Hematological Oncology·2025Open Access
Clinical effectiveness of urine DNA for minimal residual disease (MRD) monitoring of urothelial carcinoma in urine: A multicenter, prospective, observational study.
Journal of Clinical Oncology·2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma: Subgroup analysis from the phase 3 ETER100 trial.
Journal of Clinical Oncology·2025
page 1 of 14Next →

Frequent Co-authors

Liqun Zhou(18), Chuanhai Guo(17), Xuesong Li(15), Yaqi Pan(14), Hong Cai(14), Fangfang Liu(13), Yang Ke(12), Mengfei Liu(10), Dong Fang(9), Lin Yao(8), Ruiping Xu(7), Ke Yang(7), Gengyan Xiong(7), Qun He(7), Fenglei Li(6), Lei Zhang(6), Cuijian Zhang(6), Tao Ning(6), Ying Liu(6), Zhen Liu(5)